| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.265 | 19.182 | 13.955 | 14.810 | 6.279 | 8.075 | 5.269 | 3.214 | 3.486 | 4.350 |
| Total Income - EUR | 20.294 | 19.183 | 13.959 | 14.810 | 6.280 | 8.076 | 5.269 | 3.214 | 3.486 | 4.383 |
| Total Expenses - EUR | 15.769 | 18.867 | 19.406 | 19.385 | 14.061 | 15.207 | 10.619 | 9.168 | 10.330 | 6.909 |
| Gross Profit/Loss - EUR | 4.525 | 316 | -5.447 | -4.575 | -7.781 | -7.131 | -5.350 | -5.954 | -6.844 | -2.526 |
| Net Profit/Loss - EUR | 3.917 | -175 | -5.587 | -4.723 | -7.844 | -7.205 | -5.508 | -6.017 | -6.859 | -2.526 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Crismed International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.024 | 3.181 | 2.153 | 1.309 | 824 | 709 | 649 | 606 | 1.171 | 981 |
| Current Assets | 11.537 | 8.889 | 6.310 | 6.118 | 3.929 | 3.307 | 4.185 | 3.724 | 4.163 | 4.329 |
| Inventories | 1.829 | 1.871 | 1.802 | 1.771 | 1.798 | 1.711 | 2.160 | 2.210 | 2.109 | 2.214 |
| Receivables | 5.257 | 5.924 | 3.630 | 2.291 | 1.142 | 1.011 | 815 | 1.099 | 1.769 | 1.846 |
| Cash | 4.451 | 1.094 | 878 | 2.055 | 989 | 585 | 1.210 | 415 | 285 | 269 |
| Shareholders Funds | -1.443 | -1.603 | -7.163 | -11.754 | -19.370 | -26.207 | -31.134 | -37.247 | -43.993 | -46.273 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.004 | 13.673 | 15.626 | 19.181 | 24.123 | 30.224 | 35.968 | 41.578 | 49.327 | 51.596 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Crismed International S.r.l.